More Videos:

Cramer's 6 Stocks in 60 Seconds: SNV TXN UL CREE MAPP KBH (Update 1)

Tickers in this article: AGN CREE KBH MAPP SNV TXN UL
Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".

(Updates from 10:29 a.m. ET with closing information.)

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk On The Street" Wednesday:

Cramer believes a number of investors don't like Synovus Financial (SNV) , but they're wrong and this bank will go higher. That compares to Texas Instruments (TXN) , which told investors things weren't so bad, then guided below Street estimates. Investors continued to disagree, sending SNV down 4.1% Wednesday. TXN was off 1.1%.

Cramer was upbeat on Unilever (UL) because that company is a great consumer packaged-goods play, and Cree (CREE) , a company that is finally delivering new energy-efficient LED light bulbs. UL was up 2.6% but CREE jumped 22.1%.

Rounding out the group, Cramer urged investors to use caution with Map Pharmaceuticals (MAPP) , saying that Allergan (AGN) is plotting to own the migraine market. He also says be careful about KB Homes (KBH) because there's a secondary offering coming soon for the stock.

Investors ignored the caution, pushing MAP up 58.6% Wednesday. KBH ended the day 8.9% higher.

To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.

-- Written by Scott Rutt in Washington.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC